Stage 3 Classical Hodgkin's Lymphoma

Drug	Drug Name	Drug Description
DB08870	Brentuximab vedotin	A CD30-directed antibody-drug conjugate used to treat various types of lymphoma.

Drug	Drug Name	Target	Type
DB08870	Brentuximab vedotin	Tumor necrosis factor receptor superfamily member 8	target
DB08870	Brentuximab vedotin	Cytochrome P450 3A4	enzyme
DB08870	Brentuximab vedotin	ATP-binding cassette sub-family B member 5	transporter

Drug	Drug Name	Phase	Status	Count